- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01069224
Analysis of Proinflammatory Factors in the Synovial Fluid In Patients With Rotator Cuff Disease
Role of proinflammatory factors in Patients with Rotator Cuff Disease
Objective:
To measure the levels of various cytokines and metalloproteases in patients with rotator cuff disease, and control group and to determine the correlations among them.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
This study will include a consecutive series of patients who met the study inclusion criteria. Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment.
Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.
Description
Inclusion Criteria:
- Ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.
- Patients between age 18-65 scheduled for a surgery in a Shoulder unit
- Patients suffering from Rotator Cuff Disease
- Patients suffering from any noninflammatory shoulder condition which requires surgical intervention
Exclusion Criteria:
- Revision rotator cuff repair
- Recurrent shoulder surgery
- Psychiatric illness
- Inflammatory condition.
- Current use of anti-inflammatory drugs.
- Previous or current shoulder infection.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
RC tear
This study will include a consecutive series of patients who met the study inclusion criteria.
Study group patients will be diagnosed RC tear on clinical examination and imaging findings (US and MRI) that will be verified at arthroscopy in order to complete the enrollment.
|
|
Control group
Control group will include patients suffering from shoulder instability that scheduled for elective surgical repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
cytokines and MMP's levels in patients with RC pathology and in control group
Time Frame: 12 month
|
12 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Levels of pain curve by using Visual Analogue Scale
Time Frame: 12 month
|
12 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MozesG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Disease
-
Parc de Salut MarHospital Clinic of Barcelona; Hospital Universitario Fundación Jiménez Díaz; Hospital... and other collaboratorsActive, not recruitingShoulder Disease | Massive Rotator Cuff TearsSpain
-
Kyoung Hwan KohNot yet recruitingRotator Cuff DiseaseSouth Korea
-
Seoul National University HospitalRecruitingRotator Cuff DiseaseSouth Korea
-
Seoul National University HospitalCompletedRotator Cuff DiseaseKorea, Republic of
-
Seoul National University HospitalRecruiting
-
Kırklareli UniversityRecruiting
-
UConn HealthDonaghue Medical Research FoundationCompleted
-
Ullevaal University HospitalUniversity of OsloCompleted
-
Assistance Publique - Hôpitaux de ParisMerz Pharmaceuticals GmbHRecruitingDegenerative Rotator Cuff DiseaseFrance